Chau N. Nguyen

Array ( [id] => 10905643 [patent_doc_number] => 20140308657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-16 [patent_title] => 'SERINE PROTEASE INHIBITOR KAZAL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/991943 [patent_app_country] => US [patent_app_date] => 2011-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 36666 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13991943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696135 [patent_doc_number] => 20110230455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'AQUEOUS-BASED PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/149260 [patent_app_country] => US [patent_app_date] => 2011-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6996 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230455.pdf [firstpage_image] =>[orig_patent_app_number] => 13149260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8483186 [patent_doc_number] => 20120282593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'Method and Kit for Detecting Virulent Strains of Influenza Virus' [patent_app_type] => utility [patent_app_number] => 13/098770 [patent_app_country] => US [patent_app_date] => 2011-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7983 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13098770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574281 [patent_doc_number] => 20110269937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Conserved-Element Vaccines and Methods for Designing Conserved-Element Vaccines' [patent_app_type] => utility [patent_app_number] => 13/097592 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14461 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269937.pdf [firstpage_image] =>[orig_patent_app_number] => 13097592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6063250 [patent_doc_number] => 20110201088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Production of rAAV in Vero Cells Using Particular Adenovirus Helpers' [patent_app_type] => utility [patent_app_number] => 13/081169 [patent_app_country] => US [patent_app_date] => 2011-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7538 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201088.pdf [firstpage_image] =>[orig_patent_app_number] => 13081169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177367 [patent_doc_number] => 20110178004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'HEPATITIS B VIRUS PRE-S1 DERIVED SYNTHETIC POLYPEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/014070 [patent_app_country] => US [patent_app_date] => 2011-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5589 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178004.pdf [firstpage_image] =>[orig_patent_app_number] => 13014070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8950124 [patent_doc_number] => 20130195904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) HIGHLY CONSERVED AND LOW VARIANT SEQUENCES AS TARGETS FOR VACCINE AND DIAGNOSTIC APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 13/520388 [patent_app_country] => US [patent_app_date] => 2011-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21934 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8370193 [patent_doc_number] => 20120219582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'INTRANASAL SPRAY-TYPE TUBERCULOSIS VACCINE USING PARAMYXOVIRUS VECTOR' [patent_app_type] => utility [patent_app_number] => 13/389816 [patent_app_country] => US [patent_app_date] => 2010-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7101 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9054005 [patent_doc_number] => 20130251719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'BONE MARROW APLASIA WITH HAEMORRHAGIC DISEASE IN CALVES CAUSED BY NOVEL PATHOGEN' [patent_app_type] => utility [patent_app_number] => 13/503147 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14348 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8495471 [patent_doc_number] => 20120294879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'CONSENSUS SEQUENCE FOR INFLUENZA A VIRUS' [patent_app_type] => utility [patent_app_number] => 13/501339 [patent_app_country] => US [patent_app_date] => 2010-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12594 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8416685 [patent_doc_number] => 20120244185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'IMMUNIZATION STRATEGY TO PREVENT H1N1 INFECTION' [patent_app_type] => utility [patent_app_number] => 13/496482 [patent_app_country] => US [patent_app_date] => 2010-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11177 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313070 [patent_doc_number] => 20120190100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'ENZYMATIC COMPOSITION FOR THE DIGESTION OF CHICKEN EMBRYOS' [patent_app_type] => utility [patent_app_number] => 13/386168 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12532 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8464683 [patent_doc_number] => 20120269852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'Adjuvated Influenza Vaccine and Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/382639 [patent_app_country] => US [patent_app_date] => 2010-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9087 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586782 [patent_doc_number] => 20110281292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'Compositions and methods for identifying antigens which elicit an immune response' [patent_app_type] => utility [patent_app_number] => 12/829739 [patent_app_country] => US [patent_app_date] => 2010-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 30513 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281292.pdf [firstpage_image] =>[orig_patent_app_number] => 12829739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110366 [patent_doc_number] => 20110189227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'PORCINE CIRCOVIRUS TYPE 2 AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/784910 [patent_app_country] => US [patent_app_date] => 2010-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17837 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189227.pdf [firstpage_image] =>[orig_patent_app_number] => 12784910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6531290 [patent_doc_number] => 20100221280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'PLANT-PRODUCED COMPOSITIONS FOR TREATING PAPILLOMAVIRUS INFECTION AND RELATED METHODS' [patent_app_type] => utility [patent_app_number] => 12/764183 [patent_app_country] => US [patent_app_date] => 2010-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28422 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221280.pdf [firstpage_image] =>[orig_patent_app_number] => 12764183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8220822 [patent_doc_number] => 20120135034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'Non-Integrating Retroviral Vector Vaccines' [patent_app_type] => utility [patent_app_number] => 13/256216 [patent_app_country] => US [patent_app_date] => 2010-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 10597 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13256216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228928 [patent_doc_number] => 20100183666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'METHODS OF REDUCING PAPILLOMAVIRUS INFECTION USING IMMUNOMODULATORY POLYNUCLEOTIDE SEQUENCES' [patent_app_type] => utility [patent_app_number] => 12/701427 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14258 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183666.pdf [firstpage_image] =>[orig_patent_app_number] => 12701427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6626945 [patent_doc_number] => 20100172917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Binding molecules against SARS-coronavirus and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/590973 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 44331 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172917.pdf [firstpage_image] =>[orig_patent_app_number] => 12590973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6525546 [patent_doc_number] => 20100203501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Assay to detect HCV receptor binding' [patent_app_type] => utility [patent_app_number] => 12/587308 [patent_app_country] => US [patent_app_date] => 2009-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5992 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203501.pdf [firstpage_image] =>[orig_patent_app_number] => 12587308 [rel_patent_id] =>[rel_patent_doc_number] =>)